BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28738907)

  • 21. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
    Suzuki S; Uruha A; Suzuki N; Nishino I
    Autoimmun Rev; 2017 Jul; 16(7):693-700. PubMed ID: 28479486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.
    Soubrier C; Seguier J; Di Costanzo MP; Ebbo M; Bernit E; Jean E; Veit V; Swiader L; Salort-Campana E; Attarian S; De Paula AM; Kaplanski G; Durand JM; Harlé JR; Schleinitz N
    Clin Rheumatol; 2019 Dec; 38(12):3451-3458. PubMed ID: 31440919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphometric approaches to perifascicular atrophy in muscle biopsy: do they help to diagnose polymyositis?
    Paljärvi L; Snäll EV
    Neuropathol Appl Neurobiol; 1984; 10(5):333-41. PubMed ID: 6521843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.
    Salajegheh M; Kong SW; Pinkus JL; Walsh RJ; Liao A; Nazareno R; Amato AA; Krastins B; Morehouse C; Higgs BW; Jallal B; Yao Y; Sarracino DA; Parker KC; Greenberg SA
    Ann Neurol; 2010 Jan; 67(1):53-63. PubMed ID: 20186858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.
    Aouizerate J; De Antonio M; Bassez G; Gherardi RK; Berenbaum F; Guillevin L; Berezne A; Valeyre D; Maisonobe T; Dubourg O; Cosnes A; Benveniste O; Authier FJ
    Acta Neuropathol Commun; 2014 Oct; 2():154. PubMed ID: 25339355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.
    Cerbelli B; Pisano A; Colafrancesco S; Pignataro MG; Biffoni M; Berni S; De Luca A; Riccieri V; Priori R; Valesini G; d'Amati G; Giordano C
    Virchows Arch; 2018 Mar; 472(3):477-487. PubMed ID: 29147923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
    Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
    Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anomalies in perifascicular muscle fibers as an differential-diagnostic criterion. I. Perifascicular atrophy in inflammatory myopathies.
    Peiffer J; Bähr M
    Clin Neuropathol; 1987; 6(3):123-32. PubMed ID: 3608289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle pathology of antisynthetase syndrome according to antibody subtypes.
    Tanboon J; Inoue M; Hirakawa S; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Suzuki S; Nishino I
    Brain Pathol; 2023 Jul; 33(4):e13155. PubMed ID: 36882048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
    Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
    Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.
    Ukichi T; Yoshida K; Matsushima S; Kawakami G; Noda K; Furuya K; Kurosaka D
    RMD Open; 2019; 5(1):e000850. PubMed ID: 30997152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience.
    Gudipati A; Rifat S; Uppin M; Jabeen A; Mathukumalli NL; Yareeda S; Kayidhi S; Pyal A; Dhamne M; Reddy YM
    Ann Indian Acad Neurol; 2023; 26(4):408-418. PubMed ID: 37970294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
    Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
    Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Classification and Management of Inflammatory Myopathies.
    Schmidt J
    J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.
    Stenzel W; Preuße C; Allenbach Y; Pehl D; Junckerstorff R; Heppner FL; Nolte K; Aronica E; Kana V; Rushing E; Schneider U; Claeys KG; Benveniste O; Weis J; Goebel HH
    Neurology; 2015 Mar; 84(13):1346-54. PubMed ID: 25746564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.